Tolibut
Tolibut is a methylated analogue of phenibut (beta-(4-methylphenyl)-GABA) developed in the Soviet Union as an anxiolytic and analgesic with reputed neuroprotective properties. It is presumed to act as a GABA-B agonist like phenibut. Human data are almost nonexistent outside older Russian literature, and it is sold only as an obscure research chemical.
01 Overview
Tolibut is essentially the para-methyl analogue of phenibut and, like tolibut's parent compound, is thought to act on GABA-B receptors, producing anxiolysis and analgesia. It was investigated in the Soviet nootropic tradition and described as having neuroprotective and pain-modulating effects, but almost no modern, peer-reviewed human data exist.
Given its close relationship to phenibut, the most relevant safety concern is presumed dependence and rebound anxiety with regular use. Its true potency, pharmacokinetics and safety are effectively uncharacterised.
02 Mechanism
Presumed GABA-B receptor agonism as a phenibut analogue, producing anxiolytic and analgesic effects; not confirmed in modern controlled human studies.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Reported anecdotal | 250–750 mg | Oral | Anecdotal only; no validated dosing or safety data. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| AnxiolysisReported calming and anxiety-reducing effects by analogy to phenibut. | Reported | Anecdotal | |
| Analgesia / neuroprotection (claimed)Older Soviet literature describes analgesic and neuroprotective properties; not confirmed in modern trials. | Claimed | Preclinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Dependence and rebound anxietyBy analogy to phenibut, repeated use likely causes tolerance and a rebound-anxiety withdrawal. | Severe | Presumed with regular use | Unconfirmed | |
| Oversedation with depressantsCombination with alcohol or other depressants may dangerously deepen CNS depression. | Severe | Unknown | Unconfirmed |